Concepedia

M. Meinz

MM

6

Publications

827

Citations

6

H-Index

1992

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (Spain)

M. Meinz is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and natural sciences.

Top concepts

Publications per year

1992–2001

6

Publications

6

Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors

Cameron Douglas, Joseph A. D'Ippolito, G.-J. Shei et al. · Antimicrobial Agents and Chemotherapy · 1997 · 336 citations · Full text

, , +16

Discovery of Novel Antifungal (1,3)-β- <scp>d</scp> -Glucan Synthase Inhibitors

Janet C. Onishi, M. Meinz, John R. Thompson et al. · Antimicrobial Agents and Chemotherapy · 2000 · 313 citations · Full text

, , +15

Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum

M. Francisca Vicente, Angeles Cabello, Gonzalo Platas et al. · Journal of Applied Microbiology · 2001 · 53 citations

Chaetomella acutiseta produces chaetomellic acids A and B which are reversible inhibitors of farnesyl-protien transferase

R. B. Lingham, KeithC. Silverman, Gerald F. Bills et al. · Applied Microbiology and Biotechnology · 1993 · 52 citations

, , +10

Antimicrobial Activity of Viridiofungins.

Janet C. Onishi, James A. Milligan, Ángela Basilio et al. · The Journal of Antibiotics · 1997 · 39 citations · Full text

Rows per page

1–5 of 6